Methods: Data from 46 individuals with cognitive impairment and 33 individuals who visited the primary care with somatic noncognitive symptoms were analyzed. Objective: To investigate the accuracy of the CAB in a primary care population. Therefore, we investigated the accuracy of the CAB in a primary care population. However, primary care validation is lacking. The Cognitive Assessment Battery (CAB) was introduced as a sensitive tool to detect cognitive decline in primary care. World Health Organization and Alzheimer’s Disease International (2012) Dementia: a public health priority.Background: There are several cognitive assessment tools used in primary care, e.g., the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment. Wind AW, Schellevis FG, Van Staveren G, Scholten RP, Jonker C, Van Ejik JT (1997) Limitations of the mini-mental state examination in diagnosing dementia in general practice. Salthouse TA (2011) What cognitive abilities are involved in trail-making performance? Intelligence 39(4):222–232 Rossetti HC, Lacritz LH, Munro Cullum C, Weiner MF (2011) Normative data for the Montreal cognitive assessment (MoCA) in a population-based sample. Román GC (2003) Vascular dementia: distinguishing characteristics, treatment, and prevention. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. National Institute on Aging (2008) An aging world. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. Malek-Ahmadi M, Powell J, Belden CM, O’Connor K, Evans L, Coon DW, Nieri W (2015) Age- and education-adjusted normative data for the Montreal cognitive assessment (MoCA) in older adults age 70–99. Luis CA, Keegan AP, Mullan M (2009) Cross validation of the Montreal cognitive assessment in community dwelling older adults residing in the southeastern US. Looi JC, Sachdev PS (1999) Differentiation of vascular dementia from AD on neuropsychological tests. Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Hobson J (2015) The Montreal cognitive assessment (MoCA). Gluhm S, Goldstein J, Loc K, Colt A, Van Liew C, Corey-Bloom J (2013b) Cognitive performance on the mini-mental state examination and the Montreal cognitive assessment across the healthy adult lifespan. Gluhm S, Goldstein J, Brown D, Van Liew C, Gilbert PE, Corey-Bloom J (2013a) Usefulness of the Montreal cognitive assessment (MoCA) in Huntington’s disease.

Arch Clin Neuropsychol 27(2):165–175įreitas S, Simões M, Alves L, Vicente M, Santana I (2012c) Montreal cognitive assessment (MoCA): validation study for vascular dementia. J Geriatr Psychiatry Neurol 25(3):146–154įreitas S, Simões MR, Alves L, Santana I (2012b) Montreal cognitive assessment: influence of sociodemographic and health variables. J Psychiatr Res 12(3):189–198įreitas S, Alves L, Duro D, Santana I (2012a) Montreal cognitive assessment (MoCA): validation study for frontotemporal dementia. A practical method for grading the cognitive state of patients for the clinician. Dement Geriatr Cogn Disord 31(2):126–131ĭe Guise E, Leblanc J, Champoux MC, Couturier C, Alturki AY, Lamoureux J, Desjardins M, Marcoux J, Maleki M, Feyz M (2013) The mini-mental state examination and the Montreal cognitive assessment after traumatic brain injury: an early predictive study. Neurology 75(19):17–25ĭamian A, Jacobson SA, Hentz JF, Belden CM, Shill HA (2010) The Montreal cognitive assessment and the mini-mental state examination as screening instruments for cognitive impairments: item analyses and threshold scores. Can J Neurol Sci 40(3):410–415ĭalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ (2010) The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Alzheimer’s Dementia 9(2):141–150ĭagenais E, Rouleau I, Demers M, Jobin C, Roger E, Chamelian L, Duquette P (2013) Value of the MoCA test as a screening instrument in multiple sclerosis. Int J Geriatr Psychiatry 26(1):107–108Ĭordell C, Borson B, Boustani M, Chodosh J, Reuben D, Verghese J, Thies W, Fried LB (2013) Alzheimer’s association recommendations for operationalizing the detection of cognitive impairment during the medicare annual wellness visit in primary care setting. Coen RF, Cahill R, Lawlor BA (2011) Things to watch out for when using the Montreal cognitive assessment (MoCA).

Moca test score 1530